EarlySense (ארליסנס)
EarlySense is working to improve patient safety with contact-free, continuous patient monitoring. Their range of products are designed to give clinicians constant, contact-free access to a patient's level of motion, heart rate and respiratory rate (the single highest indicator of adverse events).
81.2
81.2
NaN
NaN
NaN
NaN
Valuation
$
Valuation
Funding
$
$ 39.00 M
$ 140.10 M
Funding
$ 39.00 M
$ 140.10 M
Statistics
NA
Ventures > EarlySense (ארליסנס)
EarlySense (ארליסנס)
Pending Validation
Action
EarlySense is working to improve patient safety with contact-free, continuous patient monitoring. Their range of products are designed to give clinicians constant, contact-free access to a patient's level of motion, heart rate and respiratory rate (the single highest indicator of adverse events).
- Funding
0and0